Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

RCT (n=244) found no significant difference in 2-year overall survival or cumulative incidence of relapse between a fludarabine reduced intensity conditioning regimen and a regimen of fludarabine/amsacrine/cytarabine-busulphan.

Journal of Clinical Oncology